Financing New Nuclear Capacity: Will the “Nuclear Renaissance” Be a Self-Sustaining Reaction?

Although EPAct offers a number of benefits for new nuclear capacity, a host of gaps remain, from the timing of capital formation to the residual risk that the actual cost of the first few plants will significantly exceed estimates. Securitization and related financial techniques could play a role in turning revenue streams into lumps of capital.